Published in Q J Med on January 01, 1981
Timing of infiltration of T lymphocytes induced by gluten into the small intestine in coeliac disease. J Clin Pathol (1987) 1.01
Acute gluten challenge in treated adult coeliac disease: a morphometric and enzymatic study. Gut (1985) 1.00
Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein. Gut (1992) 0.91
Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy. Clin Exp Immunol (1988) 0.91
Signs of increased leakage over the jejunal mucosa during gliadin challenge of patients with coeliac disease. Gut (1990) 0.91
Coeliac disease with histological features of peptic duodenitis: value of assessment of intraepithelial lymphocytes. J Clin Pathol (1993) 0.90
Activated eosinophils in coeliac disease. Gut (1990) 0.90
Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90
Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals. Gut (1992) 0.90
Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease. Clin Exp Immunol (1986) 0.87
Insights provided by the study of the small intestine in the child and the foetus. Gut (1989) 0.77
Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet. Aliment Pharmacol Ther (2016) 0.75
Diagnostic and Research Aspects of Small Intestinal Disaccharidases in Coeliac Disease. J Immunol Res (2017) 0.75
Electrophoretic mobilities of peptides on paper and their use in the determination of amide groups. Nature (1966) 12.65
An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet (1977) 7.89
A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut (1973) 6.09
The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol (1972) 6.07
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (1997) 3.84
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J (1979) 3.56
Transit times of food in patients with diverticulosis or irritable colon syndrome and normal subjects. Br Med J (1967) 3.51
Prevalence of colonic diverticulosis in general population of Oxford area. Br Med J (1967) 3.44
Structure of chicken muscle triose phosphate isomerase determined crystallographically at 2.5 angstrom resolution using amino acid sequence data. Nature (1975) 3.15
Course and prognosis of Crohn's disease. Gut (1976) 3.02
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut (1980) 2.81
Gastric ulcer and gastritis. Gut (1971) 2.58
Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem (1996) 2.56
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Auto-immune reactions in ulcerative colitis. Gut (1966) 2.26
Further experience in the treatment of severe attacks of ulcerative colitis. Lancet (1978) 2.25
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol (1999) 2.20
Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10
Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut (1979) 2.08
Aspirin concurrently administered with ranitidine does not delay healing of duodenal ulcer. Aust N Z J Med (1990) 2.04
Jejunal mucosal recovery in coeliac disease in relation to the degree of adherence to a gluten-free diet. Q J Med (1974) 1.95
Ulcerative colitis and pregnancy. Gut (1980) 1.90
The histological classification of duodenitis in fibreoptic biopsy specimens. Digestion (1975) 1.89
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med (2000) 1.80
Crohn's disease and carcinoma of colon. Br Med J (1968) 1.77
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77
Abnormalities in the apparently normal bowel mucosa in Crohn's disease. Lancet (1976) 1.77
Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73
An immunoperoxidase technique for the identification of gastrin-producing cells. J Clin Pathol (1974) 1.71
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. Gut (1982) 1.60
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. J Virol (2000) 1.54
The subunit structure of prealbumin. Biochem J (1971) 1.53
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene (1993) 1.50
MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene (1991) 1.49
Protected intermediate for the preparation of semisynthetic insulins. Nature (1970) 1.49
Disaccharidase activity and jejunal morphology in coeliac disease. Q J Med (1972) 1.48
The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis. Scand J Gastroenterol (1980) 1.46
Small bowel strictures after blunt abdominal trauma. Br J Surg (1979) 1.44
Hypolactasia and the irritable colon syndrome. Scand J Gastroenterol (1972) 1.42
Conventional versus on-demand therapy for duodenal ulcer: results of a controlled therapeutic trial. Am J Gastroenterol (1990) 1.40
Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis. Lancet (1979) 1.40
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol (1982) 1.40
Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine. Clin Exp Immunol (1974) 1.39
Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun (1997) 1.38
The preparation of a semisynthetic tritiated insulin with a specific radioactivity of up to 20 Curies per millimole. Biochem J (1975) 1.37
The amino acid sequence of the B-protein of bacteriophage ZJ-2. Biochem J (1972) 1.36
Active-site labelling of triose phosphate isomerase. The reaction of bromohydroxyacetone phosphate with a unique glutamic acid residue and the migration of the label to tyrosine. Biochem J (1972) 1.35
CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A (2005) 1.34
Protection of peptides of biological origin for use as intermediates in the chemical synthesis of proteins. Nature (1969) 1.33
Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis (1966) 1.32
Stimulation of lymphocytes from patients with coeliac disease by a subfraction of gluten. Lancet (1976) 1.31
Lack of harmful effect of oats on small-intestinal mucosa in coeliac disease. Br Med J (1974) 1.31
A quantitative study of the influence of fixation on immunoperoxidase staining of rectal mucosal plasma cells. J Clin Pathol (1980) 1.30
Propulsion and retropulsion of normal colonic contents. Am J Dig Dis (1971) 1.30
Studies on the subunit structure and amino acid sequence of trisoe phosphate isomerase from chicken breast muscle. Biochem J (1974) 1.30
Cirrhosis associated with the Australia antigen in an infant who acquired hepatitis from her mother. Br Med J (1970) 1.29
Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial. Br Med J (1972) 1.28
Spectrum of acute poisoning in adults (10 year experience). J Assoc Physicians India (1984) 1.27
Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Histopathology (2000) 1.27
The liver in ulcerative colitis. Q J Med (1971) 1.27
Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut (1977) 1.26
Gastritis duodenitis, and circulating levels of gastrin in duodenal ulcer before and after vagotomy. Gut (1976) 1.25
Cerebral venous thrombosis as a complication of ulcerative colitis. Am J Dig Dis (1967) 1.25
Rapid preparation of human insulin and insulin analogues in high yield by enzyme-assisted semi-synthesis. Biochem J (1983) 1.23
Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site. Diabetologia (1979) 1.22
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors. J Biol Chem (1999) 1.22
Comparison of various treatments for irritable bowel syndrome. Br Med J (1980) 1.20
Pancreaticobiliary ductal union in biliary diseases. An endoscopic retrograde cholangiopancreatographic study. Gastroenterology (1989) 1.20
Rectal histology in acute bacillary dysentery. Gastroenterology (1986) 1.19
The role of various cereals in coeliac disease. Q J Med (1978) 1.19
Uniquely labelled active site sequence in chicken muscle triose phosphate isomerase. Nature (1970) 1.19
A functioning complex between tryptic fragments of cytochrome c. A route to the production of semisynthetic analogues. Biochem J (1977) 1.19
The preparation of protected fragments of lysozyme for semisynthesis. Biochem J (1976) 1.18
Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16
The liver in Crohn's disease. Q J Med (1971) 1.16
Amino acid sequence determination by g.l.c.--mass spectrometry of permethylated peptides. Optimization of the formation of chemical derivatives at the 2-10 nmol level. Biochem J (1983) 1.16
Circulating antibodies to cow's milk proteins in ulcerative colitis. Gut (1972) 1.16
Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer (1985) 1.15
A second activation peptide from bovine cationic trypsinogen. Biochem J (1977) 1.14
Use of neutron activation in the characterization of small quantities of nucleic acids. Nature (1966) 1.13
Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease. Gut (1974) 1.13